A study conducted in Wales reveals that the shingles vaccine could reduce the risk of dementia in older adults.

An unexpected idea is emerging in medicine: vaccines may protect not only against infections, but also against dementia. The ...

Flu vaccine season is upon us, but did you know there could be a hidden additional cognitive benefit which comes with your ...

A Welsh health policy provided a rare opportunity for researchers to examine the vaccine's real-life impact on dementia risk.

The new 0.5mL single-dose, prefilled syringe has the same composition as the original 2-vial presentation but removes the need for reconstitution. The Food and Drug Administration (FDA) has approved a ...

It’s a rite of passage — or probably should be — for adults upon reaching 50 years of age: getting vaccinated for shingles. Currently, the two-dose Shingrix vaccine, which is the only shingles vaccine ...

Dynavax Technologies Corporation (NASDAQ:DVAX) announced topline results from Part 1 of its randomized, observer-blinded, and active-controlled Phase 1/2 clinical trial of Z-1018, a shingles vaccine ...

Beijing Luzhu Biotechnology Co. Ltd.’s shingles vaccine LZ-901 outperformed GSK plc’s Shingrix (HZ/su) vaccine in a head-to-head phase III trial. A recombinant herpes zoster vaccine candidate ...

The incidence of herpes zoster and herpes zoster ophthalmicus increase after age 50, and both are associated with an increased risk of cardiovascular complications. For patients ages 50 and older, the ...

New Brunswick sticks out as the only Atlantic province without shingles vaccine coverage. That's something that CanAge, ...

Dynavax Technologies (NASDAQ:DVAX) added ~7% in the premarket on Thursday after the company said that its experimental shingles vaccine Z-1018 caused an immune response comparable to that of GSK’s ...